Alexander David: Dedicated, independent broker providing online share dealing, investing & share trading

Research Ratings

Shares appear to be undervalued relative to the market, its peers and/or future growth potential. The company may be profitable and have revenues or otherwise the outlook appears to be profitable in terms of recovery or growth. Absolute return is expected to increase by over 10% in the next 12 months.

We believe that the long run prospects of the Company are positive; its risk reward ratio advocates purchase of the stock, although the investment risk is higher than our typical “buy” recommendation. Operations may be in the early stages of development and the current price reflects both the risks and the possible rewards for shareholders. In the short term, the stock may be subject to high volatility and continue to trade at a discount to the market. Absolute return is expected to increase by over 10% in the next 12 months provided the company can avoid any legal or other pitfalls.

Our research concludes the stock is fairly priced at current levels. Shareholders should await further developments to see how this might impact the company and its share price. Absolute return is expected to within the range -10% and +10% over the next 12 months.

Sell at the price indicated in order to secure profits since the stock was originally recommended.

Shares appear to be overvalued and do not reflect current prospects or status. The future of the company’s operations may be at risk or additional funding may be required. Absolute return is expected to decrease by over 10% in the next 12 months.